• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

甲基丙二酸血症MMACHC基因c.482G>A突变患者临床资料及随访分析

Clinical analysis and outcome of patients with c. 482G >A variant of MMACHC gene in cblC type methylmalonic acidemia

摘要:

目的 了解甲基丙二酸血症(methylmalonic acidemia,MMA)MMACHC基因c.482G>A(p.R161Q)突变患者临床表现、治疗效果及预后.方法 回顾性分析75例携带MMACHC基因c.482G>A(p.R161Q)突变的MMA患者的临床表现、质谱检测结果、基因突变类型、治疗效果及预后.结果 75例患者中57例(76%)来自新生儿筛查,仅1例发病;18例未筛查患者中2例因同胞确诊而检测后诊断本病,未发病,余16例均为临床病例.17例发病患者中,发病年龄中位数为12岁(10 d~26岁),其中迟发型患者12例(70.6%),主要表现为学习成绩下降、记忆减退、表达不畅、运动能力倒退;早发型患者5例(29.4%)以抽搐、发育落后多见.全部患者均为维生素B12有效型.治疗后患者血中丙酰肉碱、丙酰肉碱与乙酰肉碱比值、尿中甲基丙二酸、甲基枸橼酸及血同型半胱氨酸水平均下降(P<0.01).经新生儿筛查确诊患者均发育正常.发病患者中3例经治疗发育正常,其余患者遗有不同程度的智力和(或)运动能力障碍.结论 MMACHC基因c.482G>A(p.R161Q)突变与迟发型MMA相关,对羟钴胺的反应优于其他突变类型.来自新生儿筛查确诊的患者预后良好,一旦发病,致残率较高,故新生儿筛查是预防此病的较好方法.

更多
abstracts:

Objective To explore the clinical manifestations, treatment and outcomes of patients with c. 482G>A ( p. R161Q ) variant of MMACHC gene in cblC type methylmalonic acidemia ( MMA ) . Methods The clinical manifestations, mass spectrometry results, genotypes, treatment and outcomes of 75 patients with cblC type MMAcarryingc.482G>A(p.R161Q)variantwereretrospectivelyanalyzed.Results Ofthe75patients,57(76%) were from newborn screening and one of them had an onset. Among the rest 18 unscreened patients, 2 were diagnosed after their full sisters' or brothers' diagnosis, the others were clinical patients. There were 17 clinical patients, with the medium age of onset 12 years old (10 days~26 years old). 12 late onset patients (70.6%) presented with poor academic performance, memory loss, poor expression, and decreased exercise capacity, while 5 early onset patients (29.4%) presented with convulsion and delay of development. All patients were vitamin B12-responsive. The levels of blood propionylcarnitine, the ratio of propionylcarnitine to acetylcarnitine, urinary methylmalonic acid and methyldecanoic acid, and plasma homocysteine were significantly decreased after treatment (P< 0.01). All patients diagnosed from newborn screening had normal development. However, only 3 clinical patients had a rather normal outcomes and the others remained different levels of intelligence and ( or ) motor dysfunction after treatment. Conclusion The c.482G>A ( p. R161Q) variant of MMACHC gene is associated with late onset cblC type MMA. Patients with this variant have a better response to hydroxycobalamin than other variants. The outcome of patients diagnosed from the newborn screening is good. When symptoms occur, the disability rate is often high. Therefore, newborn screening is a recommended method to prevent this disease.

More
作者: 鄂慧姝 [1] 韩连书 [1] 叶军 [1] 邱文娟 [1] 张惠文 [1] 梁黎黎 [1] 王瑜 [1] 王建国 [1] 季文君 [1] 陈婷 [1] 顾学范 [1]
期刊: 《中华内分泌代谢杂志》2019年35卷7期 581-585页 ISTICPKUCSCD
栏目名称: 临床研究
DOI: 10.3760/cma.j.issn.1000-6699.2019.07.008
发布时间: 2019-08-09
基金项目:
国家重点研发计划 上海市体育局科研项目( 15Z028) National key R&D Program of China Program of Sports Bureau of Shanghai City
  • 浏览:1499
  • 下载:410

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷